3006.93.10.00/Blinded Placebo Aspirin Tablets for Migraine Trial/Germany

Blinded Placebo Aspirin Tablets for Migraine Trial from Germany

These are inert placebo tablets identical in appearance to aspirin, packaged with actual aspirin medicinal preparations in blinded kits for a recognized clinical trial on migraine relief. They fall under HTS 3006.93.10.00 as placebos put up in measured doses, packaged alongside medicinal preparations for double-blinded studies. This ensures neither participants nor researchers know who receives the active drug.

Duty Rate — Germany → United States

15%

Rate breakdown

9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter

9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter

Calculate with your customs value Verify with the Tariff Assistant

Import Tips

• Obtain FDA Investigational New Drug (IND) approval and provide clinical trial protocol documentation to Customs for clearance

• Label kits clearly as 'Clinical Trial Materials - Not for Resale' to avoid misclassification as commercial medicaments

• Verify sterility certificates and measured dose packaging to prevent reclassification under general pharmaceutical headings